>>> WisdomTree announces it surpassed $50 bln in assets under management

WisdomTree announces it surpassed $50 bln in assets under management  

"While we are experiencing record inflows of $9.7 billion led by our pioneering currency hedged family this year, the foundation of our growth rests in our larger commitment to innovation in ETFs. We have been a consistent asset gatherer since launching our first ETFs in 2006, with growth accelerating in recent years."


{WETF US Equity DES<GO<<Go>}

>>> T-Mobile US: Gabelli reiterating TMUS as top Pick for 2015

T-Mobile US: Gabelli reiterating TMUS as top Pick for 2015

Gabelli notes TMUS continues to be their top Telecom pick for 2015 with the company's solid spectrum position and opportunities to expand the MetroPCS prepaid brand to new geographic areas. The wireless sector in the U.S. continues to consolidate, and TMUS should command a 7.0-7.5x FY EBITDA multiple in a buyout/consolidation scenario. 2016 PMV of $50 per share.

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: RMGN +14.3%, SHLO +4.8%, MOBI +4.2%, WUBA +3.8%

M&A news: RTI +44.4% ( Alcoa (AA) to acquire RTI for $41/share in a stock for stock ), PNK +24.7% (David Faber tweets 'Gaming and Leisure (GLPI) springs bear hug on PNK, trying to combine with its real estate assets; GLPI says deal worth $36/share to PNK holders')

Select metals/mining stocks trading higher: ABX +1.9%, AU +1.5%, GOLD +1.4%, GDX +1.3%, NEM +1.3%, MT +1%

Other news: CTIC +20.4% (CTI BioPharma and Baxter (BAX) announce positive Phase 3 persist-1 trial results of pacritinib for patients with myelofibrosis), OPXA +12.3% (amended its option and license agreement with Merck Serono (MKGAY.PK unit) and will receive a $3 mln payment), HTBX +10.2% (receives US FDA Fast Track Designation for HS-410 ), WLL +9.7% (WSJ report that the company is considering sale), CAMT +7.8% (announces the receipt of an order for 9 Eagle-i systems), PHMD +4.3% (cont strength from last week), MPO +3.5% (Interim CEO Peter Hill resigns, steps down from Board; co will appoint Frederic Brace as interim President and Chief Executive Officer), XOMA +3.1% ( presents positive Phase 1 XOMA 358 data), BXE +2.7% (proved reserves +30% in 2014, with production +74%), GM +2.6% (authorizes initial $5 bln share repurchase program beginning immediately; reaffirms FY15 EBIT targets and long term guidance), HZNP +1.6% (announces that pre-clinical data show treatment with Interferon Gamma improved signs of disease severity of rare bone disease), URBN +1.6% (favorable commentary on Friday's Mad Money), SPPI +1.4% (announces that its New Drug Application for Captisol-Enabled Melphalan has been accepted by the FDA), JACK +1% (favorable commentary on Friday's Mad Money), AAPL +0.8% (in advance of product event; also target raised to $145 from $130 at Macquarie), FCAU +0.8% (NHTSA confirms FCAU recalls certain 2008-2010 models over ignition switch issue)

Analyst comments: AVEO +14% (upgraded to Sector Perform from Underperform at RBC Capital Mkts), UTIW +4.4% (upgraded to Outperform from Mkt Perform at FBR Capital), JNPR +2.2% (upgraded to Buy from Neutral at Goldman), URBN +1.6% (target raised to $46 from $42 at Brean Capital), MPEL +1.2% (upgraded to Neutral from Underweight at JP Morgan), DRH +0.8% (upgraded to Outperform from Neutral at Robert W. Baird)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: LITB -4.2%, POZN -4.2%, MCD -1.2%, (reports Feb global comps -1.7%; -4% in the US) BITA -0.7%

M&A news: AA -2% (Alcoa to acquire RTI for $41/share in a stock for stock)

Other news: ACRX -42.8% (provides update on the timing and potential content of the resubmission of the New Drug Application for Zalviso; receives correspondence from the FDA that an additional clinical study is needed to assess the risk of inadvertent dispensing and overall risk of dispensing failures), NBG -7.7% (EU Pres comments regarding Greece reform proposals), IBN -2.9% (Sensex down over 2% overnight), RDY -0.8% (Sensex down over 2% overnight)

Analyst comments: BBRY -3.9% (downgraded to Sell from Neutral at Goldman), CLF -1.6% (downgraded to Sell from Hold at Axiom Capital), KORS -1.6% (cautious comments and target lowered to $72 from $76 at Sterne Agee), TSM -1.5% (downgraded to Underperform from Sector Perform at Pacific Crest), LAZ -0.9% (downgraded to Neutral from Positive at Susquehanna), LEN -0.7% (downgraded to Neutral from Buy at Buckingham Research)

NY Post : Schwarzman on path to $1B payday in a single year

When it comes to big paydays, private equity is the place to be.
Fuhgeddabout the big banks, which are under siege from shareholders to slim down or break up. Even hedgies are taking their lumps for carving outsize pay while often failing to outperform the broader market.
In fact, according to calculations by Crain’s New York Business, Blackstone boss Steve Schwarzman is well positioned to become the first leader of a public company to be paid more than $1 billion in a single year. He received $690 million in 2014.
This year could prove even richer for Schwarzman, considering that Blackstone has more than 80 companies to shop around, the paper reported.

>>> US Early premarket gappers

Early premarket gappers
Gapping up: RTI +28.3%, AVEO +23.3%, WLL +7.6%, BITA +6%, PHMD +4.9%, UTIW +4.4%, JNPR +3.9%, WUBA +3.1%, ABX +2.3%, GOLD +2.2%, GDX +1.6%, FCEL +1.4%, DB +1.4%, DAL +1.4%, GM +1.3%, AA +1.2%, AU +1.2%, RIG +1%, MT +1%, STO +1%, AAPL +0.9%, NEM +0.9%, MYL +0.5%

Gapping down: NBG -9.1%, BBRY -4.1%, CLF -2.6%, TSEM -2.1%, KORS -1.4%, RIO -1.2%, IBN -1%, AMZN -0.9%, RDY -0.8%

FT : Swimming with sharks

A great piece on the US bond market by Tracy Alloway and Mike Mackenzie has plenty to consider on Monday. Some will be familiar to those in the market — there have been a ton of inflows and liquidity has dried up — but ponder also some of the behaviour described when it comes to allocating bond sales.

Because rules for bond allocations are not set in stone, most bankers and fund managers do not believe they are doing anything illegal, though some expressed misgivings about a practice they describe as more art than science.

A long boom, insatiable demand for what banks are selling, possible different treatment of the large and the small buyer. Any of it starting to sound familiar? Investigators like to stroll along the sand once the tide has gone out. Recall the look at initial public offering practices during the dot com era by Elliot Spitzer, for instance. But remember too the tendency in finance for an ethical line to be edged past in the search for advantage. At the time practices can seem merely aggressive, or cynical, but when attention turns to them much later it becomes obvious the line is now distant. Think the treatment of soft commissions, client entertaining, analysts saying one thing in public and another in private, libor or foreign exchange traders traders chatting, or naked shorting, for instance.

Which isn’t to say there is widespread bad behaviour in the bond market, far from it. Rather it is to point out how the cycles in these things go. As retail investors have piled into bond funds over the last decade, any market correction resulting in losses may prompt more attention on what is going on.

Do read the whole thing, but here’s another extract:

Speaking on condition of anonymity, several senior bankers said the largest bond managers exert disproportionate influence on the size and price of new debt sales. The behind-closed-doors process by which new corporate bonds are priced and then doled out to investors means that opportunities for questionable — though not necessarily illegal — behaviour exist, these bankers say.

Big bond funds that trade with a bank in the secondary market are more likely to receive a larger allocation of new debt deals underwritten by the firm — a classic case of quid pro quo behaviour, according to bankers. The most powerful bond funds are also able to alter the price of a debt deal, often pushing for new bonds to be sold at a wider, or more profitable, spread for investors, they add.

One former credit trader at a bank recalled keeping track of which clients do the most “favours” for the firm to ensure good allocations in desirable new deals. A former senior banker at a well-known US bank said more than two-thirds of the firm’s credit trading revenues were tied to its underwriting business. Others described their competitors creating fake orders to get more bonds that could then be given to their biggest clients.

A former syndicate banker at a large US bank described being goaded by a sales manager to alter the pricing of a bond offering to satisfy a powerful buyside client: “Then I have to basically lie to the issuer and tell them they can’t get a better deal. One time, I even had to modify the limits in an order book that they requested to make it look like a tighter deal wasn’t in the cards.”

Bankers would “rather allocate to the big guys at a wider level than smaller guys at a tighter level”, says David Schawel, portfolio manager at Square 1 Bank.

As Tracy and Mike point out, the SEC devotes half of one person’s time to corporate bonds, versus more than 100 focused on the stock market. For anyone feeling uncomfortable in the water, it might be a good idea to get out early.

WSJ : GM Plans Share Buyback, Averting Proxy Fight

GM Plans Share Buyback, Averting Proxy Fight
Investor Harry J. Wilson to drop request to join board in light of repurchase plan

General Motors Co. as soon as Monday will disclose plans to return billions of dollars to shareholders, a move that is expected to avoid a potential proxy fight with investor Harry J. Wilson, said people familiar with the matter.

Mr. Wilson will drop a previous request to join the Detroit auto maker’s board in light of the buyback plan, the people said. GM plans to repurchase shares over time in an amount less than the $8 billion Mr. Wilson previously proposed, they said. The size of the buyback and its time frame couldn’t be learned.

Mr. Wilson in February put GM on notice that he intended to nominate himself for a board seat at the company’s upcoming annual meeting and propose an $8 billion stock buyback. Mr. Wilson has criticized GM’s stock price, cash management and operating performance.

Mr. Wilson and hedge funds backing him have held discussions with GM representatives over the past several weeks, according to people familiar with the matter, culminating in talks over the weekend that led both sides to reach a deal that is expected to avoid acrimony, at least in the short term.

GM’s board likely needed to decide soon whether to put Mr. Wilson in its proxy to have ballot materials ready before the company’s annual meeting, which could take place as soon as June. A rejection, or lack of some kind of settlement, could have led Mr. Wilson to mount a proxy fight.

Mr. Wilson wants GM to manage its cash better. The auto maker, flush with $25 billion, faces financial pressures in the months ahead, including a possible hefty fine from the Justice Department over the company’s failure for more than a decade to recall vehicles equipped with defective ignition switches. The auto maker has said it plans to weigh returning cash to shareholders as soon as the second half of this year. The auto maker views its plans as responsive to all shareholders and not solely driven by Mr. Wilson, said a person familiar with the mater.

Last week, Mr. Wilson beat back criticism over a compensation arrangement with hedge funds that are backing him related to his possible service on GM’s board. He could receive anywhere from 2% to 4% of the upside of their GM shares over three years. Mr. Wilson owns about 30,000 GM shares, while the funds backing him collectively own more than 30 million, or about 2% of the shares outstanding.

Mr. Wilson, among the architects of GM’s 2009 government bailout and bankruptcy restructuring, last week was criticized by Warren Buffett , who suggested the pay arrangement created a short-term incentive. “It’s just not the way to run a business,” said Mr. Buffett, whose Berkshire Hathaway Inc. is a GM shareholder, on CNBC. Mr. Wilson responded that he has held GM stock since 2011 and expects to for many years, and is willing to lock up any payouts in GM stock “for an extended period of time.”

Such compensation deals have sparked controversy at other companies including Dow Chemical Co. Many company executives and advisers deride the practice as a “golden leash” that compromises independence and a director’s duty to serve all shareholders and weigh the long-term.

Activist investors contend such payouts motivate their director selections to shake up boardrooms and increase value for all shareholders.

Mr. Wilson ended up on the board of Sotheby’s last year as part of activist investor Daniel Loeb ’s settlement with the auction house for three board seats. Domenico De Sole, lead independent director at Sotheby’s, bemoaned the proxy fight. “I thought it was an unfortunate expenditure of money for someone who turned out to be an exemplary board member,” said Mr. De Sole, a former Gucci chief executive. He said Mr. Wilson “really knows how to draw the line between governing and managing” and can work with executives without overstepping boundaries.

Steve Wolosky, a partner at law firm Olshan Frome Wolosky LLP who represents activist investors, says Mr. Wilson’s compensation is justified and his offer to lock up any payments “clearly evidences his long-term commitment to improving value at GM.” Mr. Buffett later during the CNBC interview said: “If Harry has a ton of stock himself that he’s going to put away for a long period of time, that’s one thing.”

Still, some management lawyers find Mr. Wilson’s deal problematic.

“I don’t care how long he locks up the payouts,” said Avrohom J. Kess, a partner at Simpson Thacher Bartlett LLP. He said Mr. Wilson instead should defer any payments unless GM’s stock is up a decade from now. “That’s putting your money where your mouth is.”

The pay agreements are sometimes fraught but have improved over the years, said Robert Jackson, a Columbia University Law School professor. The debate over Mr. Wilson’s arrangement “is a bit of a red herring,” he said, adding that three-year compensation horizons for directors are “absolutely standard.”

>>> TIM/Oi talks cool down - Veja

TIM/Oi talks cool down 

The negotiations for a possible acquisition of TIM Participacoes by Oi have cooled down, Veja reported. The brief, unsourced Portuguese-language article did not disclose the reasons for the talks cooling.

Oi hired BTG Pactual in August last year to act as agent to help it prepare a proposal for the acquisition of TIM, which is controlled by Telecom Italia, as reported.

 
 Veja 

>>> AA to acquire RTI (RTI US ) for $41/share in $1.5B stock deal

AA to acquire co for $41/share in $1.5B stock deal 
- Company has signed a definitive agreement to acquire RTI International Metals, Inc. (NYSE:RTI), a global supplier of titanium and specialty metal products and services for the commercial aerospace, defense, energy and medical device markets.
- Expected to contribute $1.2 billion in revenues in 2019, up from $794 million generated in 2014; RTIs profitability expected to reach 25 percent EBITDA margin in 2019, up from 14.5 percent in 2014

- Alcoa will acquire all outstanding shares of RTI in a stock-for-stock transaction. RTI shareholders will receive 2.8315 Alcoa shares for each RTI share, representing a value of $41 per RTI share based on Alcoas closing price on March 6, 2015. The transaction has an enterprise value of $1.5 billion, including $330 million of RTI cash on hand and up to $517 million in RTIs convertible notes.